Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Tricida | 2022 | Post Ipo Debt | $125.0M | Menlo Park |
| Nightfall | 2022 | Series B | $40.0M | San Francisco |
| Dgraph Labs | 2022 | Seed | $6.0M | San Francisco |
| Arch Data, Inc (fka Meltano) | 2022 | Seed | $8.2M | Austin |
| Kelonia Therapeutics | 2022 | Series A | $50.0M | Boston |
| Decodable | 2022 | Series A | $20.0M | San Francisco |
| Socrates.AI, Inc. | 2022 | Series A | Undisclosed | San Francisco |
| Concentric Analgesics | 2022 | Convertible Note | $20.0M | San Francisco |
| Mythic Therapeutics | 2021 | Series B | $103.0M | Waltham |
| Ablaze Pharmaceuticals | 2021 | Series A | $75.0M | Jingan |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 76 | Tricida | Post Ipo Debt | $125.0M | Menlo Park, United States |
| 77 | Nightfall | Series B | $40.0M | San Francisco, United States |
| 78 | Dgraph Labs | Seed | $6.0M | San Francisco, United States |
| 79 | Arch Data, Inc (fka Meltano) | Seed | $8.2M | Austin, United States |
| 80 | Kelonia Therapeutics | Series A | $50.0M | Boston, United States |
| 81 | Decodable | Series A | $20.0M | San Francisco, United States |
| 82 | Socrates.AI, Inc. | Series A | Undisclosed | San Francisco, United States |
| 83 | Concentric Analgesics | Convertible Note | $20.0M | San Francisco, United States |
| 84 | Mythic Therapeutics | Series B | $103.0M | Waltham, United States |
| 85 | Ablaze Pharmaceuticals | Series A | $75.0M | Jingan, China |
Tricida operates in the healthcare industry focusing on pharmaceutical business.
Nightfall is a cloud data protection platform that uses machine learning to identify and detect business-critical data.
Dgraph is a fast, transactional, native and distributed graph database.
Arch transforms data into decisions with your AI Data Analyst—a unified, intelligent platform for analytics and insights, backed by experts.
Kelonia Therapeutics is developing a new wave of genetic medicines using its next-generation vivo gene delivery platform.
Decodable is a serverless data integration and engineering platform for streaming data.
Socrates AI brings deep expertise in Artificial Intelligence.
Concentric Analgesics is a biotechnology company that develops non-opioid therapeutics for the management of acute and chronic pain.
Mythic Therapeutics is a biotechnology company focused on a new generation of groundbreaking cancer therapeutics.
Ablaze Pharmaceuticals is a clinical-stage pharmaceutical company.
Stride Health is a provider of an insurance recommendation platform designed to offer health insurance services.
Rebellion Defense's mission is to help the US and its partners outpace tomorrow's adversary.
Rarible is a community-centric NFT marketplace and infrastructure provider
Percipient.ai is a provider of an artificial intelligence advanced analytics platform designed to provide solutions for Intelligence.
Encoded Therapeutics is a Harnessing the regulatory genome to create next-generation molecular therapies.
Cyteir is developing the next generation of synthetic lethal therapies to treat cancer.
Beckon provides data management and real-time marketing intelligence for better, faster decisions to grow your brand.
Federation Bio is a microbial therapeutics company targeting diseases in which the human microbiome can play a curative role.
PROPS creates a decentralized model for digital media that uses blockchain technology to reward the contributors that power the network.
Corvidia Therapeutics focuses on the research and development of transformative therapies for cardio-renal diseases.
10X Genomics ELV solutions and security systems company that provides an innovative genomics platform.
Attune Pharmaceuticals is a private biotechnology company.
Sojournix is a biotechnology company developing innovative medicines for women's health and endocrine disorders.
The workflow optimization platform for commercial real estate professionals
Hua Medicine is a clinical-stage, innovative drug development company in China.
Venrock has invested in 112 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Venrock's top investment sectors include Biotechnology, Health Care, Medical, Pharmaceutical, Software. The firm invests across 45 different industry categories.
Among tracked funding rounds, Rebellion Defense received $150.0M in a Series B round. Venrock's total known invested capital is $3.7B.
Venrock's average investment size is $45.6M across its portfolio of 112 companies.
Recent Venrock portfolio additions include Tricida, Nightfall, Dgraph Labs, Arch Data, Inc (fka Meltano), Kelonia Therapeutics. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors